Lantern Pharma Inc.
LTRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001763950
No open-market purchases or sales by Lantern Pharma Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $12.0M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Lantern Pharma Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 30 | 33 | +3 |
| Shares | 2.27M | 2.28M | +5.96K (+0.3%) |
| Value | $9.89M | $6.91M | −$2.98M (−30.2%) |
New holders (6)
Institutions that held Lantern Pharma Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 32,895 | $99.7K | 0.00% |
| Colony Group, LLC | 15,982 | $48.4K | 0.00% |
| CIBC Private Wealth Group, LLC | 15,432 | $46.8K | 0.00% |
| Cetera Investment Advisers | 12,228 | $37.1K | 0.00% |
| Curio Wealth, LLC | 2,000 | $6.68K | 0.00% |
| JPMorgan Chase & Co | 69 | $209 | 0.00% |
Sold out (3)
Institutions that held Lantern Pharma Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Commonwealth Equity Services, LLC | 18,161 | $79.0K |
| Two Sigma Investments, LP | 16,041 | $69.8K |
| Allworth Financial LP | 2,100 | $9.13K |